Argos Therapeutics, Inc. Announces Plans for HIV Eradication Study

Published: Jul 02, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

DURHAM, N.C., July 1, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, unveiled a new development strategy for AGS-004, a personalized immunotherapy for HIV patients, at the Towards an HIV Cure Symposium on June 29th and 30th, which precedes the 7th Annual International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Kuala Lumpur, Malaysia.

Help employers find you! Check out all the jobs and post your resume.

Back to news